Last reviewed · How we verify
NCT03201497
Prospective Registration of Severe Pneumocystis Jiroveci Pneumonia Requiring ICU Admission
trial in Pneumocystis Jiroveci Pneumonia in 300 participants. Status unknown.
1 July 2019
Quick facts
| Lead sponsor | Peking Union Medical College Hospital |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 300 |
| Start date | 1 July 2017 |
| Primary completion | 1 July 2019 |
| Estimated completion | 1 August 2019 |
Conditions studied
- Pneumocystis Jiroveci Pneumonia — all drugs for Pneumocystis Jiroveci Pneumonia →
- Intensive Care Unit — all drugs for Intensive Care Unit →
Sponsor
Peking Union Medical College Hospital
Who can join
18 and older, any sex, with Pneumocystis Jiroveci Pneumonia or Intensive Care Unit. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
the investigators aim to set up a multicenter registry study for severe PJP requiring ICU admission. The purpose of this study is 1. to establish a prospective severe PJP registry about clinical characteristics, laboratory and radiographic findings, critical care management and outcomes. 2. to explore the predictive factors associated with outcomes ; 3. to compare the difference between PJP patients with HIV and without HIV infection.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT03201497
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Peking Union Medical College Hospital trials
Trials by the same sponsor.
- NCT07466251 — PCSK9 Inhibitor for Intracranial Atherosclerosis Related Acute Ischemic Stroke · Phase 4 · not yet recruiting
- NCT06743321 — Speech-to-speech Voice-cloning Care (SVCC) to Improve ICU-acquired Anxiety for Critically Ill Patients · NA · not yet recruiting
- NCT07590336 — 68Ga-NYM207 PET/CT Imaging in Hepatocellular Carcinoma · Phase 1, PHASE2 · not yet recruiting
- NCT07515976 — Mapping of Genomic Structural Variations in Major Birth Defects · not yet recruiting
- NCT07386756 — Early Precise Identification and Intervention Strategies for Individuals at High Risk of Prediabetes · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03201497 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Peking Union Medical College Hospital
- Last refreshed: 29 June 2017
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03201497.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing